Investigation of CEA as a Biomarker for Prognostic Utility and Using Cardiac Troponin to Assess Radiation Therapy-Induced Cardiotoxicity in Patients with Lung Cancer Undergoing Thoracic Radiation | Synapse
February 28, 2026
Investigation of CEA as a Biomarker for Prognostic Utility and Using Cardiac Troponin to Assess Radiation Therapy-Induced Cardiotoxicity in Patients with Lung Cancer Undergoing Thoracic Radiation
Key Points
Key points are not available for this paper at this time.